DAFTAR PUSTAKA
Attis, M.G., Vollmer, R.T., 2007. Mitotic Rate in Melanoma a Reexamination. Am J Clin Pathol 2007 127:380-384. doi: 10.1309/LB7RTC61B7LC6HJ6.
Azimi, F., Scolyer, R.A., Rumcheva, P,. et al., 2012. Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients with Cutaneous Melanoma. Journal of Clinical Oncology30(21): 2678-2683.
Balch, C.M., Gershenwald, J.E., Soong, S., et al., 2009. Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology27(36): 6199-6206.
Balch, C.M., Gershenwald, J.E., Soong, S., et al., 2010. Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of Clinical Oncology28(14): 2452-2459.
Bandarchi, B., Ma, L., Navab, R., et al., 2010. From Melanocyte to Metastatic Malignant Melanoma. Dermatology Research and Practice. doi:10.1155/2010/583748
Bogunovic, D., O’Neill,D.W., Levy, I.B., et al., 2009. Immune Profile and Mitotic Index of Metastatic Melanoma Lesions Enhance Clinical Staging in Predicting Patient Survival. PNAS106(48): 20429-20434. Busam, K. J., Antonescu, C. R., Marghoob, A. A. et al., 2001. Histologi
Classification of Tumor-Infiltrating Lymphocytes in Primary Cutaneous Malignant Melanoma. Am J Clin Pathol 2001;115: 856-860.
Chung, K.T., Nilson, E.H., Case, M.J. et al., 1973. Estimation of Growth Rate from the Mitotic Index. In: Thomas, N.E., Kricker, A., Waxweiler, W.T. et al., 2014. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study. JAMA Dermatol 150(12): 1306-1314.
de Vries, E., Bray, F., Coebergh, J.W., et al., 2006. Melanocytic tumours. In: LeBoit, P.E., Burg, G., Weedon, D., et al., 2006. Pathology & Genetics Skin Tumours. Lyon: International Agency for Research on Cancer Press: 52-65.
de Vries, E., Nijsten, T.E.C., Visser, O., et al., 2007. Superior Survival of Females Among 10 538 Dutch Melanoma Patients Is Independent of Breslow Thickness, Histologic Type and Tumor Site. Annals of Oncology. doi:10.1093/annonc/mdm498.
Donizy, P., Zietek, M., Leskiewicz, M., et al., 2015. High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients. Analytical Cellular Pathology. http://dx.doi.org/10.1155/2015/975436.
Forman, D., Bray, F., Brewster, D.H., et al., 2014. Cancer Incidence in Five Continents vol. X. Lyon: International Agency for Research on Cancer (164).
Garbe, C., Büttner, P., Bertz, J., et al., 1995. Primary Cutaneous Melanoma: Prognostic Classification of Anatomic Location. Cancer 1995(75):2492-8.
GLOBOCAN, 2012. Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. International Agency for Research on Cancer.
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=36 0 [Accessed June 22th 2015]
Goldstein, B.G., and Goldstein, A.O., 2001. Diagnosis and Management of Malignant Melanoma. American Family Physician 63(7): 1359-1386. Hale, C.S., Qian, M., Ma, M.W. et al., 2013. Mitotic Rate in Melanoma:
Prognostic Value of Immunostaining and Computer-Assisted Image Analysis. Am J Surg Pathol 37(6): 882–889.
Herbst, M.C., 2014. Fact Sheet on Malignant Melanoma. Cancer Association of South Africa: 1-15.
Hernberg, M., Turunen, J.P., Muhonen, T. et al., 1997. Tumor Infiltrating Lymphocytes in Metastatic Melanomas Receiving Chemoimmunotherapy. In: Rao, U.M.N., Lee, S.J., Luo, W., et al., 2010. Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma. Am J Clin Pathol 133: 646-653.
Holterhues, C., 2011. Burden of Melanoma. Rotterdam: Optima Grafische Communicatie: 7-10.
Houghton, A.N., Guevara-patiño, J.A., 2004. Immune Recognition of Self in Immunity Against Cancer. J. Clin. Invest. 114: 468–471 (2004). doi:10.1172/JCI200422685.
Junowo, Juniarto, A.Z., 2000. Biologi Sel. Jakarta: Penerbit Buku Kedokteran EGC: 75-83.
King, R.J.B., 2000. Cancer Biology, 2nd ed. Pearson Education Limited: 58-68, 148-157.
Larsen, T.E., Grude, T.H., 1978. A Retrospective Histological Study of 669 Cases of Primary Cutaneous Malignant Melanoma in Clinical Stage I: 3, The Relationship Between the Tumor-Associated Lymphocyte Infiltration and Age and Sex, Tumor Cell Type, Pigmentation, Cellular Atypia, Mitotic Count, Depth of Invasion, Ulceration, Tumor Type and Prognosis. In: Taylor, R.C., Patel, A., Panageas, K.S., et al., 2007. Tumor-infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma. J Clin Oncol 25:869-875. DOI: 10.1200/JCO.2006.08.9755.
Lee, S.J., Lim, H.J., Choi, Y.H., et al., 2013. The Clinical Significance of Tumor-Infiltrating Lymphocytes and Microscopic Satellites in Acral Melanoma in a Korean Population. Ann Dermatol 25(1):61-66. http://dx.doi.org/10.5021/ad.2013.25.1.61.
Ma, M.W., Medicherla, R.C., Qian, M., et al., 2012. Immune Response in Melanoma: an In-Depth Analysis of The Primary Tumor and Corresponding Sentinel Lymph Node. National Institute of Health. doi:10.1038/modpathol.2012.43.
MacKie, R.M., Hauschild, A., and Eggermont, A.M.M., 2009. Epidemiology of Invasive Cutaneous Melanoma. Annals of Oncology 20(6): vi1–vi7. Maio, M., 2012. Melanoma as a Model Tumour for Immuno-Oncology. Annals of
Oncology 23 (Supplement 8): viii 10. doi:10.1093/annonc/mds257.
McCourt, C., Dolaé, O., and Gormley, G., 2014. Malignant Melanoma: A Pictorial Review. Ulster Med J 83(2): 103-110.
Miller, A.J., and Mihm, M.C., 2006. Mechanisms of Disease Melanoma. N Engl J Med 355: 51-65.
Nagorsen, D., Scheibenbogen, C., Marincola, F.M., et al., 2003. Natural T Cell Immunity Against Cancer. American Association for Cancer Research 9: 4296-4303.
Négrier, S., Fervers, B., Bailly, C., et al., 2001. Cutaneous Melanoma. British Journal of Cancer 84(2): 81–85.
Paek, S.C., Sober, A.J., Tsao, H., et al., 2008. Cutaneous Melanoma. In: Wolff, K., Goldsmith, L.A., Katz S.I., et al., 2008. Fitzpatrick’s Dermatology in General Medicine, 7th ed. McGraw-Hill Companies: 1134-1149 Pasaribu, E.T., 2006. Kontroversi Profilaksis Elektif Node Diseksi dalam
Penanganan Melanoma Maligna. Majalah Kedokteran Nusantara 39(4): 433-436.
Putra, I.B., 2008. Tumor Kulit yang Berasal dari “Melanocytes System”. USU e-Repository.
Rager, E.L., Bridgeford, E.P., and Ollila, D.W., 2005. Cutaneous Melanoma: Update on Prevention, Screening, Diagnosis, and Treatment. American Family Physician 72(2): 269-279.
Rao, U.M.N., Lee, S.J., Luo, W., et al., 2010. Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma. Am J Clin Pathol 133: 646-653.
Reddy, S.S., Boukovalas, S., Barnica V., Zhu, F., et al., 2014. Tumor Infiltrating- Lymphocytes and Their Role as a Prognostic Indicator for Melanoma. J Surgery7(2): 01-07.
Siegel, R., Ma, J., Zou, Z., et al., 2014. Cancer Statistics, 2014. CA Cancer J Clin 64(1): 2-29.
Spaner, D., Radvany, L., Miller, R.G., 1998. Immunology Related to Cancer. In: Tannock, I.F., Hill, R.P., 1998. The Basic Science of Oncology, 3rd ed. The McGraw-Hill Companies: 240-260.
Sukardja, I D.G., 2000. Onkologi Klinik, 2nd ed. Surabaya: Airlangga University Press: 41-44.
Suyatno, Pasaribu, E.T., 2010. Bedah Onkologi Diagnosis dan Terapi. Jakarta: Sagung Seto: 155-169.
Swetter, S.M., Geller, A.C., and Kirkwood, J.M., 2004. Melanoma in the Older Person. Cancer Network.
Taylor, R.C., Patel, A., Panageas, K.S., et al., 2007. Tumor-infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma. J Clin Oncol 25:869-875. DOI: 10.1200/JCO.2006.08.9755.
Teixeira, V., Vieira R., Coutinho I., et al., 2013. Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre. Journal of Skin Cancer. http://dx.doi.org/10.1155/2013/904701.
Thomas, N.E., Busam, K.J., From, L., et al., 2013. Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study. Journal of Clinical Oncology31(33): 4252-4259.
Thompson, J.F., Soong, J., Balch, C.M., et al., 2011. Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of Clinical Oncology29(16): 2199-2205.
Northeastern Brazil from 2000 to 2010. Anais Brasileiros de Dermatologia. http://dx.doi.org/10.1590/abd1806-4841.20132036. Zeng, G., 2001. MHC Class II-Restricted Tumor Antigens Recognized by CD4
